Key facts
- Everystate’s last known valuation is $2.4M (Jul 2025).
- It has raised $410K; the latest was Seed Round ($410K) in Jul 2025.
- Notable investors include Era VC.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Everystate
- ·The full record, as it builds
Funding rounds
No funding rounds for Everystate are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Everystate
Provider of functional mushroom-based nutritional blends intended for daily wellness support. The company combines ingredients such as Lion's Mane, Cordyceps, Reishi, and Tremella with natural bases like coffee, matcha, and cacao to create consumable products that promote energy and skin health, enabling consumers to integrate plant-based, sustainable supplements into their routines for improved mental clarity, physical vitality, and emotional balance.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Wokingham, United Kingdom
- Founded
- 2023
- Employees
- 6
- Website
- everystate.co/
- Ownership
- Privately Held (backing)
Everystate doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Everystate shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Everystate in its N-PORT filings yet. We sweep new filings monthly.